» Articles » PMID: 34993578

Telehealth in Rheumatology: the 2021 Arab League of Rheumatology Best Practice Guidelines

Abstract

To develop Best Practice Guidelines (BPG) for the use of Telehealth in Rheumatology in the Arab region, to identify the main barriers and facilitators of telehealth, and to provide rheumatologists with a practical toolkit for the implementation of telehealth. Guidelines were drafted by a core steering committee from the Arab League of Associations for Rheumatology (ArLAR) after performing a literature search. A multidisciplinary task force (TF), including 18 rheumatologists, 2 patients, and 2 regulators from 15 Arab countries, assessed the BPG using 3 rounds of anonymous online voting by modified Delphi process. The statements were included in the final BPG without further voting if ≥ 80% of TF members indicated high agreement. The voting on barriers and facilitators was performed through one voting round. The toolkit was developed based on available literature and discussions during the Delphi rounds. Four General Principles and twelve Statements were formulated. A teleconsultation was specifically defined for the purpose of these guidelines. The concept of choice in telehealth was highlighted, emphasizing patient confidentiality, medical information security, rheumatologist's clinical judgment, and local jurisdictional regulations. The top barrier for telehealth was the concern about the quality of care. The toolkit emphasized technical aspects of teleconsultation and proposed a triage system. The ArLAR BPG provide rheumatologists with a series of strategies about the most reliable, productive, and rational approaches to apply telehealth.

Citing Articles

Rheumatology in the digital health era: status quo and quo vadis?.

Knitza J, Gupta L, Hugle T Nat Rev Rheumatol. 2024; 20(12):747-759.

PMID: 39482466 DOI: 10.1038/s41584-024-01177-7.


From Sand to Excellence: A Deep Dive into Abu Dhabi's Rheumatology Landscape.

Alnaqbi K, Fazal F, Namas R Mediterr J Rheumatol. 2024; 35(1):73-82.

PMID: 38736955 PMC: 11082762. DOI: 10.31138/mjr.011123.fst.


Selection of criteria for a telemedicine framework for designing, implementing, monitoring and evaluating telemedicine interventions: Validation using a modified Delphi process.

Katz C, Robles N, Novillo-Ortiz D, Saigi-Rubio F Digit Health. 2024; 10:20552076241251951.

PMID: 38726219 PMC: 11080763. DOI: 10.1177/20552076241251951.


Why do we fall short in reaching equity in telerheumatology?.

Hmamouchi I, Ziade N Health Policy Technol. 2022; 11(1):100609.

PMID: 35228989 PMC: 8864891. DOI: 10.1016/j.hlpt.2022.100609.

References
1.
Mistry J, Sharif M, Prideaux A, Smith C, Sumbwanyambe M, Sibley M . Use of rheumatoid arthritis impact of disease (RAID) in routine care; identification of DAS28 remission and unmet patient-reported outcomes. Rheumatol Adv Pract. 2020; 4(2):rkaa013. PMC: 7359769. DOI: 10.1093/rap/rkaa013. View

2.
Kessler E, Sherman A, Becker M . Decreasing patient cost and travel time through pediatric rheumatology telemedicine visits. Pediatr Rheumatol Online J. 2016; 14(1):54. PMC: 5029100. DOI: 10.1186/s12969-016-0116-2. View

3.
Taylor P . Adopting PROs in virtual and outpatient management of RA. Nat Rev Rheumatol. 2020; 16(9):477-478. PMC: 7274267. DOI: 10.1038/s41584-020-0449-6. View

4.
Maciver A, Hollinger H, Carolan C . Tele-health interventions to support self-management in adults with rheumatoid arthritis: a systematic review. Rheumatol Int. 2021; 41(8):1399-1418. PMC: 8245362. DOI: 10.1007/s00296-021-04907-2. View

5.
de Thurah A, Stengaard-Pedersen K, Axelsen M, Fredberg U, Schougaard L, Hjollund N . Tele-Health Followup Strategy for Tight Control of Disease Activity in Rheumatoid Arthritis: Results of a Randomized Controlled Trial. Arthritis Care Res (Hoboken). 2017; 70(3):353-360. DOI: 10.1002/acr.23280. View